{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:42:30Z","timestamp":1790739750739,"version":"4.1.0"},"reference-count":41,"publisher":"BMJ","issue":"8","funder":[{"name":"association pour la recherche contre le cancer"},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005736","name":"Universit\u00e9 Paris Diderot","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020986","name":"Innate Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020986","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2018,11,5]]},"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Primary GI T-cell lymphoproliferative diseases (T-LPD) are heterogeneous entities, which raise difficult diagnosis and therapeutic challenges. We have recently provided evidences that lymphomas complicating coeliac disease (CD) arise from innate-like lymphocytes, which may carry NK receptors (NKRs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>NKRs expression was compared by flow cytometry in intraepithelial lymphocytes (IEL) from CD, type I or type II refractory CD (RCD). NKp46 was next assessed by immunohistochemistry in paraffin-embedded biopsies from 204 patients with CD, RCDI, RCDII or GI T-cell lymphomas and from a validation cohort of 61 patients. The cytotoxic properties of an anti-NKp46 monoclonal antibody conjugated to pyrrolobenzodiazepine (PBD) was tested<jats:italic>ex vivo<\/jats:italic>in human primary tumour cells isolated from fresh duodenal biopsies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>NKp46 (but not CD94, NKG2A, NKG2C, NKG2D) was significantly more expressed by malignant RCDII IEL than by normal IEL in CD and RCDI. In paraffin biopsies, detection of &gt;25 NKp46+ IEL\u2009per 100 epithelial cells discriminated RCDII from CD and RCDI. NKp46 was also detected in enteropathy-associated T-cell lymphomas (EATL, 24\/29) and in monomorphic epitheliotropic intestinal T-cell lymphomas (MEITL, 4\/4) but not in indolent T-LPD (0\/15). Treatment with anti-NKp46-PBD could efficiently and selectively kill human NKp46+ primary\u2009IEL<jats:italic>ex vivo<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>NKp46 is a novel biomarker useful for diagnosis and therapeutic stratification of GI T-LPD. Strong preclinical rationale identifies anti-NKp46-PBD as a promising therapy for RCDII, EATL and MEITL.<\/jats:p><\/jats:sec>","DOI":"10.1136\/gutjnl-2018-317371","type":"journal-article","created":{"date-parts":[[2018,11,17]],"date-time":"2018-11-17T17:19:27Z","timestamp":1542475167000},"page":"1396-1405","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":62,"title":["NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study"],"prefix":"10.1136","volume":"68","author":[{"given":"Morgane","family":"Cheminant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bruneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Malamut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sibon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Guegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"van Gils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Cording","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Trinquand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Verkarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Lhermitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Brousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Jannot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherine","family":"Khater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Frenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Delarue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambroise","family":"Mar\u00e7ais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris JJ","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Macintyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Asnafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Pouyet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Bonnafous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Lhospice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry Jo","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Meresse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Cellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Cerf-Bensussan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,11,17]]},"reference":[{"key":"2024111022400862000_68.8.1396.1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569"},{"key":"2024111022400862000_68.8.1396.2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000369542","article-title":"Enteropathy-associated T-cell lymphoma: improving treatment strategies","volume":"33","author":"Nijeboer","year":"2015","journal-title":"Dig Dis"},{"key":"2024111022400862000_68.8.1396.3","doi-asserted-by":"crossref","unstructured":"Mutzbauer G , Maurus K , Buszello C , et al . SYK expression in monomorphic epitheliotropic intestinal T-cell lymphoma. Mod Pathol 2018;31.doi:10.1038\/modpathol.2017.145","DOI":"10.1038\/modpathol.2017.145"},{"key":"2024111022400862000_68.8.1396.4","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.5.662"},{"key":"2024111022400862000_68.8.1396.5","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-007-0475-7"},{"key":"2024111022400862000_68.8.1396.6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068343","article-title":"Indolent small intestinal CD4+ T-cell lymphoma is a distinct entity with unique biologic and clinical features","volume":"8","author":"Margolskee","year":"2013","journal-title":"PLoS One"},{"key":"2024111022400862000_68.8.1396.7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-512830"},{"key":"2024111022400862000_68.8.1396.8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.cgh.2013.11.028","article-title":"Small intestinal CD4+ T-cell lymphoma is a heterogenous entity with common pathology features","volume":"12","author":"Malamut","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2024111022400862000_68.8.1396.9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-031104"},{"key":"2024111022400862000_68.8.1396.10","doi-asserted-by":"publisher","DOI":"10.1159\/000103891"},{"key":"2024111022400862000_68.8.1396.11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(00)02481-8","article-title":"Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma","volume":"356","author":"Cellier","year":"2000","journal-title":"The Lancet"},{"key":"2024111022400862000_68.8.1396.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70530-X"},{"key":"2024111022400862000_68.8.1396.13","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.09.069"},{"key":"2024111022400862000_68.8.1396.14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.dld.2012.12.001","article-title":"Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study","volume":"45","author":"Malamut","year":"2013","journal-title":"Dig Liver Dis"},{"key":"2024111022400862000_68.8.1396.15","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.10.013"},{"key":"2024111022400862000_68.8.1396.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-012-0322-z"},{"key":"2024111022400862000_68.8.1396.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)01047-3"},{"key":"2024111022400862000_68.8.1396.18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI41344"},{"key":"2024111022400862000_68.8.1396.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.07.018"},{"key":"2024111022400862000_68.8.1396.20","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/00042737-199910000-00019","article-title":"The histopathology of coeliac disease: time for a standardized report scheme for pathologists","volume":"11","author":"Oberhuber","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2024111022400862000_68.8.1396.21","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91819-P"},{"key":"2024111022400862000_68.8.1396.22","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1021\/mp500666j","article-title":"Site-specific conjugation of monomethyl auristatin e to anti-cd30 antibodies improves their pharmacokinetics and therapeutic index in rodent models","volume":"12","author":"Lhospice","year":"2015","journal-title":"Mol Pharm"},{"key":"2024111022400862000_68.8.1396.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70173-9"},{"key":"2024111022400862000_68.8.1396.24","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1053\/j.gastro.2012.08.028","article-title":"Large granular lymphocytic leukemia: a treatable form of refractory celiac disease","volume":"143","author":"Malamut","year":"2012","journal-title":"Gastroenterology"},{"key":"2024111022400862000_68.8.1396.25","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-311816"},{"key":"2024111022400862000_68.8.1396.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.09.005"},{"key":"2024111022400862000_68.8.1396.27","doi-asserted-by":"publisher","DOI":"10.1172\/JCI43242"},{"key":"2024111022400862000_68.8.1396.28","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.13"},{"key":"2024111022400862000_68.8.1396.29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12602"},{"key":"2024111022400862000_68.8.1396.30","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.178"},{"key":"2024111022400862000_68.8.1396.31","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20160894"},{"key":"2024111022400862000_68.8.1396.32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7025"},{"key":"2024111022400862000_68.8.1396.33","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1200\/JCO.2000.18.4.795","article-title":"Enteropathy-type intestinal t-cell lymphoma: clinical features and treatment of 31 patients in a single center","volume":"18","author":"Gale","year":"2000","journal-title":"Journal of Clinical Oncology"},{"key":"2024111022400862000_68.8.1396.34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-231324"},{"key":"2024111022400862000_68.8.1396.35","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-02-335216"},{"key":"2024111022400862000_68.8.1396.36","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23213"},{"key":"2024111022400862000_68.8.1396.37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ajh.23992","article-title":"Treatment response in enteropathy associated T-cell lymphoma; survival in a large multicenter cohort","volume":"90","author":"Nijeboer","year":"2015","journal-title":"Am J Hematol"},{"key":"2024111022400862000_68.8.1396.38","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1182\/blood.V95.11.3628","article-title":"Expression of CD94\/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas","volume":"95","author":"Haedicke","year":"2000","journal-title":"Blood"},{"key":"2024111022400862000_68.8.1396.39","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.54.3.224"},{"key":"2024111022400862000_68.8.1396.40","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPWGG69MCZOWMM"},{"key":"2024111022400862000_68.8.1396.41","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/cas.13512","article-title":"Expression of activating natural killer-cell receptors is a hallmark of the innate-like T-cell neoplasm in peripheral T-cell lymphomas","volume":"109","author":"Uemura","year":"2018","journal-title":"Cancer Sci"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2018-317371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T06:41:16Z","timestamp":1731307276000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2018-317371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,17]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,7,5]]},"published-print":{"date-parts":[[2019,8]]}},"alternative-id":["10.1136\/gutjnl-2018-317371"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2018-317371","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,17]]}}}